| Steroid hormone biosynthesis |
2.18 |
8.44e-3 |
43/61 (70.49%) |
AKR1C2;UGT2B4;AKR1C1;...
|
| Steroid biosynthesis |
2.17 |
4.22e-3 |
19/20 (95%) |
EBP;MSMO1;FDFT1;...
|
| Allograft rejection |
2.17 |
2.81e-3 |
32/38 (84.21%) |
HLA-DQA1;HLA-F;HLA-G;...
|
| Fat digestion and absorption |
2.05 |
4.22e-3 |
35/43 (81.4%) |
CD36;ACAT2;PLPP3;...
|
| Lysosome |
2.02 |
3.38e-3 |
115/128 (89.84%) |
NEU1;LAMP1;MCOLN1;...
|
| Graft-versus-host disease |
2.01 |
2.81e-3 |
32/42 (76.19%) |
HLA-DQA1;HLA-F;HLA-G;...
|
| Metabolism of xenobiotics by cytochrome P450 |
2.00 |
2.41e-3 |
49/77 (63.64%) |
ADH1B;UGT2B4;AKR1C1;...
|
| Cholesterol metabolism |
1.90 |
6.33e-3 |
44/50 (88%) |
CD36;NPC2;SOAT1;...
|
| Retinol metabolism |
1.89 |
5.63e-3 |
41/68 (60.29%) |
ADH1B;RDH11;UGT2B4;...
|
| Type I diabetes mellitus |
1.89 |
5.07e-3 |
38/43 (88.37%) |
HLA-DQA1;PTPRN2;HLA-F;...
|
| PPAR signaling pathway |
1.77 |
1.38e-2 |
66/74 (89.19%) |
SCD;CD36;FABP4;...
|
| Complement and coagulation cascades |
1.70 |
2.74e-2 |
76/85 (89.41%) |
CFB;C1R;C1S;...
|
| Fatty acid degradation |
1.68 |
3.44e-2 |
40/43 (93.02%) |
ADH1B;ACAT2;ACADSB;...
|
| Primary bile acid biosynthesis |
1.68 |
3.20e-2 |
15/17 (88.24%) |
CYP39A1;AMACR;AKR1C4;...
|
| Tyrosine metabolism |
1.67 |
3.49e-2 |
30/36 (83.33%) |
ADH1B;MAOB;TYRP1;...
|
| Relaxin signaling pathway |
-1.67 |
5.00e-2 |
114/129 (88.37%) |
PIK3CA;MAPK11;INSL5;...
|
| Leukocyte transendothelial migration |
-1.73 |
3.85e-2 |
90/114 (78.95%) |
ARHGAP35;ICAM1;CTNNA2;...
|
| Proteoglycans in cancer |
-1.74 |
4.40e-2 |
172/205 (83.9%) |
CCND1;MAP2K1;PRKACA;...
|
| Yersinia infection |
-1.76 |
3.61e-2 |
120/137 (87.59%) |
MAP2K1;MAPK1;ITGA5;...
|
| Colorectal cancer |
-1.77 |
4.10e-2 |
84/86 (97.67%) |
MAPK9;SOS2;GADD45B;...
|
| Adherens junction |
-1.78 |
4.84e-2 |
63/71 (88.73%) |
FER;CTNNA3;NLK;...
|
| Focal adhesion |
-1.93 |
0.00e+0 |
180/201 (89.55%) |
RAF1;PAK4;PARVA;...
|
| Tight junction |
-1.94 |
0.00e+0 |
130/169 (76.92%) |
CCND1;PRKACA;MYL6;...
|
| Bacterial invasion of epithelial cells |
-2.08 |
0.00e+0 |
59/77 (76.62%) |
CTNNA2;ITGA5;ACTR3;...
|
